Also listed on Lockbody Therapeutics Ltd., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends May 16, 2039 · High confidence
20-year base term ends Mar 12, 2039
Filed Sep 11, 2020 as application 16/980,015 · Granted Jun 13, 2023
Base term plus 65 days of patent term adjustment (USPTO delay)
Today
2019
2039
Clock starts
Mar 12, 2019
Mar 12, 2019
Term ends
May 16, 2039
May 16, 2039
Granted
Jun 13, 2023
Jun 13, 2023
base term
patent term adjustment
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
65
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 65 days past its 20-year base term on prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 12, 2019, when application PCT/EP2019/056178, the earliest non-provisional in its chain, was filed (this one was filed Sep 11, 2020) | Mar 12, 2039 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +65 days, USPTO patent term adjustment record | May 16, 2039 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | May 16, 2039 | High confidence |
This family
| US 11,673,960 | this patent May 2039 | May 2039 |
| US 12,415,861 | In force Apr 2039 | Apr 2039 |
| Application 19/304,080 | Pending not computed | not computed |
3 of 4 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 23, 2020 Reel 53856, frame 961 | Finlay, William James Jonathan | Ultrahuman Six Limited | Assignment of Assignor's Interest |
| Nov 24, 2020 Reel 54461, frame 27 | Ultrahuman Six Limited | Lockbody Therapeutics Ltd. | Change of Name |
| Oct 4, 2021 Reel 57710, frame 82 | Apcintex Limited; Janpix Limited; Capella Bioscience Ltd.; Lockbody Therapeutics Ltd.; Ultrahuman Two Limited; Ultrahuman Four Limited; Morphogen-IX Limited; Orexia Therapeutics Limited; Cardiokine Biopharma LLC; Palladio Biosciences, Inc.; Pearlriver Bio GmbH; Z Factor Limited | Cocoon S.A. LLC | Security Interest |
| May 20, 2022 Reel 61603, frame 778 | Lockbody Therapeutics Ltd. | Lockbody Therapeutics Ltd. | Change of Address |
| Oct 20, 2023 Reel 65293, frame 294 | Lockbody Therapeutics Ltd. | Centessa Pharmaceuticals (UK) Limited | Assignment of Assignor's Interest |
| Dec 31, 2024 Reel 69708, frame 39 | Centessa Pharmaceuticals (UK) Limited | Oxford Finance LLC | Security Interest |
| Jun 12, 2026 Reel 75737, frame 1 | Cocoon S.A. LLC | Apcintex Limited; Janpix Limited; Capella Bioscience Ltd.; Lockbody Therapeutics Ltd.; Ultrahuman Two Limited; Ultrahuman Four Limited; Morphogen-IX Limited; Orexia Therapeutics Limited; Cardiokine Biopharma LLC; Centessa Biosciences, Inc.; Pearlriver Bio GmbH; Z Factor Limited | Release of Security Interest |
| Jun 12, 2026 reel/frame not recorded | Cocoon S.A. LLC | Apcintex Limited | Release of Security Interest |
| Jun 12, 2026 reel/frame not recorded | Cocoon S.A. LLC | Janpix Limited | Release of Security Interest |
| Jun 12, 2026 reel/frame not recorded | Cocoon S.A. LLC | Capella Bioscience Ltd. | Release of Security Interest |
| Jun 12, 2026 reel/frame not recorded | Cocoon S.A. LLC | Lockbody Therapeutics Ltd. | Release of Security Interest |
| Jun 12, 2026 reel/frame not recorded | Cocoon S.A. LLC | Ultrahuman Two Limited | Release of Security Interest |
| Jun 12, 2026 reel/frame not recorded | Cocoon S.A. LLC | Ultrahuman Four Limited | Release of Security Interest |
| Jun 12, 2026 reel/frame not recorded | Cocoon S.A. LLC | Morphogen-IX Limited | Release of Security Interest |
| Jun 12, 2026 reel/frame not recorded | Cocoon S.A. LLC | Orexia Therapeutics Limited | Release of Security Interest |
| Jun 12, 2026 reel/frame not recorded | Cocoon S.A. LLC | Cardiokine Biopharma LLC | Release of Security Interest |
| Jun 12, 2026 reel/frame not recorded | Cocoon S.A. LLC | Centessa Biosciences, Inc. | Release of Security Interest |
| Jun 12, 2026 reel/frame not recorded | Cocoon S.A. LLC | Pearlriver Bio GmbH | Release of Security Interest |
| Jun 12, 2026 reel/frame not recorded | Cocoon S.A. LLC | Z Factor Limited | Release of Security Interest |
| Jun 24, 2026 Reel 75069, frame 879 | Oxford Finance LLC | Centessa Pharmaceuticals (UK) Limited | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
May 2039
Term ends May 16, 2039. Maintenance fees still fall due before then
Note
The 65 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
3
later US patents cite this one
That is top 25% of utility patents granted in 2023 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.